$PBIO's technology has been developed for use in t
Post# of 42085
The company’s patented Ultra Sheer Technology Platform employs a nanotechnology technique that uses ultra-high pressure to sheer oil droplets to such a small size that they effectively dissolve in water tremendously increasing the absorption properties of the CBD within the body. Current methods of processing CBD oil create an end product that is not easily absorbed by the body and less than 10% of the CBD oil processed using today's inferior technologies is absorbed by the body when consumed.
The BaroShear K45 uses its proprietary, breakthrough technology to process CBD oil into an end product that is far more potent as up to 90% of the CBD can now be absorbed by the body when consumed which is now leading to the BaroShear 45 quickly becoming the industry standard for the processing of CBD oil. This incredible increase in the body's absorption level of the CBD is due to the improved physics that are created by processing CBD oil using Pressure BioSciences' BaroShear K45's superior nanotechnology based processing technology.
The resulting CBD product is as much as 9 times more potent and can be easily infused into CBD infused beverages and edibles while substantially decreasing the quantity of CBD necessary to create the same desired effect resulting in greatly improved efficiencies and increased profitability for CBD manufacturers. The significant decrease in the quantity of CBD being used to manufacture the exact same potency CBD infused products is leading to substantially increased margins throughout the industry.
Pressure BioSciences is creating a paradigm shift in the processing of CBD oil that is leading to the company experiencing exponential sales growth for its BaroShear K45 and an increased potential for enormous profits. The popularity of the BaroShear K45 is happening at a very opportune time in the CBD industry's history. With the passage of the 2018 Farm Bill, entrepreneurs are rushing to grow hemp and extract CBD oil that is water soluble to be used as an ingredient that is infused into beverages and edibles. Projected revenue for CBD infused beverages alone is expected to be $220 million by 2022